RB
Robert Bruce (Bruce & Co) disclosed reduced in Abbvie
Robert Bruce (Bruce & Co) filed a 13F change in Abbvie (00287Y109) on 2025-02-11, covering period end 2024-12-31.
Action
Reduced
Capital
$24,433,750 current disclosed value
Institutional 13F Signals1 evidence source
Why it matters
This signal is selected by portfolio impact within the manager filing, while the full filing change list remains available in the briefing.
Full Filing Changes
41 changes from Robert Bruce (Bruce & Co), filed 2025-02-11 for period end 2024-12-31.
$311.4M portfolio value
| Stock | Action | Change | Current | Portfolio Impact |
|---|---|---|---|---|
N00985106 AerCap Holdings | Increased | $6.8M | $14.4M | 2.18% |
23586506 Uhaul B | Reduced | -$6.6M | $29.9M | 2.13% |
302571104 Nextera Energy | Reduced | -$5.6M | $22.6M | 1.80% |
00287Y109 Abbvie | Reduced | -$4.5M | $24.4M | 1.44% |
00206R102 AT & T | Reduced | -$4.0M | $17.6M | 1.30% |
589331107 Merck | Reduced | -$3.2M | $21.2M | 1.02% |
125896100 CMS Energy | Reduced | -$2.8M | $19.1M | 0.91% |
237266101 Darling Ingredients | Reduced | -$2.7M | $4.8M | 0.87% |
91911K102 Bausch Health | Reduced | -$2.3M | $1.4M | 0.74% |
50015M109 Kodiak Sciences | Increased | $2.1M | $3.2M | 0.68% |
651639106 Newmont | Reduced | -$1.6M | $3.7M | 0.52% |
532457108 Eli Lilly | New | $1.5M | $1.5M | 0.50% |
H11356104 Bunge | Reduced | -$1.5M | $6.2M | 0.48% |
26441C204 Duke Energy | Reduced | -$1.5M | $21.1M | 0.48% |
45774W108 Insteel | Reduced | -$1.4M | $9.3M | 0.45% |
449585108 IGM Bioscience | Reduced | -$1.0M | $611,000 | 0.33% |
39483102 Archer Daniels | Reduced | -$922,000 | $5.1M | 0.30% |
717081103 Pfizer | Reduced | -$785,509 | $7.2M | 0.25% |
23586100 Uhaul | Reduced | -$713,384 | $5.1M | 0.23% |
31189P102 Fate Theraputics | Reduced | -$647,500 | $577,500 | 0.21% |
2824100 Abbott | Reduced | -$589,510 | $16.8M | 0.19% |
N51517105 Lava Theraputics | Reduced | -$548,031 | $733,280 | 0.18% |
37833100 Apple | Increased | $491,238 | $9.7M | 0.16% |
925815102 Vicor | Increased | $435,400 | $3.4M | 0.14% |
05379B107 Avista | Reduced | -$427,180 | $7.4M | 0.14% |
20002101 Allstate | Increased | $409,770 | $25.2M | 0.13% |
868459108 Supernus | Increased | $408,883 | $3.0M | 0.13% |
98389B100 XEL Energy | Increased | $333,840 | $13.1M | 0.11% |
44209104 Ashland | Reduced | -$232,650 | $1.1M | 0.07% |
142038108 Caribou Biosciences | Reduced | -$190,500 | $397,500 | 0.06% |
268311107 EDAP | Reduced | -$188,242 | $1.2M | 0.06% |
71535D106 Personalis | Reduced | -$151,660 | $1.5M | 0.05% |
68622V106 Organon | Reduced | -$134,604 | $465,504 | 0.04% |
749607107 RLI | Reduced | -$109,020 | $3.4M | 0.04% |
934423104 Warner Bros. Discovery | Sold out | -$97,771 | $0 | 0.03% |
65443P102 908 Devices | Reduced | -$86,723 | $150,229 | 0.03% |
92939U106 WEC Energy | Reduced | -$62,688 | $370,988 | 0.02% |
82968B103 XM Sirius | Reduced | -$45,365 | $1.3M | 0.01% |
92556V106 Viatris | Increased | $42,523 | $725,574 | 0.01% |
56400P706 Mannkind | Increased | $33,600 | $1.3M | 0.01% |
00430HAC6 Accelerate Diagnostic | Increased | $32,122 | $1.3M | 0.01% |